Benda Pharmaceutical, Inc. (BPMA.OB) Enters Into Advisory Agreements with CRT Capital Group LLC and EastGate Financial, Inc.
Benda Pharmaceutical, Inc (BPMA.OB), a China-based pharmaceutical company that produces traditional Chinese and conventional medicines, announced that the company has entered into a financial advisory agreement with CRT Capital Group LLC. According to the terms discussed in this agreement, CRT will assist Benda in evaluating their strategic and financial corporate alternatives, including joint ventures, spin-offs, financing, or other capital market transactions. Furthermore, Benda has also entered into a financial advisory agreement with EastGate Financial, Inc. EastGate will help Benda apply for a listing on the American Stock Exchange and help Benda identify and choose an AMEX specialist firm. Yiqing Wan,…